Phase 1/2 study of NEXI-001 donor-derived multi-antigen specific CD8+ T cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic transplantation Meeting Abstract
| Authors: | Al Malki, M. M.; Vasu, S.; Modi, D.; Perales, M. A.; Ghoda, L. Y.; Bui, D.; Edavana, V.; Lu, E.; Kim, S.; Suarez, L.; Oelke, M.; Bednarik, D.; Knight, R. D.; Varela, J. C. |
| Abstract Title: | Phase 1/2 study of NEXI-001 donor-derived multi-antigen specific CD8+ T cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic transplantation |
| Meeting Title: | 63nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000835740103026 |
| DOI: | 10.1182/blood-2021-152419 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4819 -- Hybrid meeting, also took place online -- Source: Wos |
